X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA CADILA HEALTHCARE ELDER PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x -0.2 36.1 - View Chart
P/BV x 0.1 9.3 1.1% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
CADILA HEALTHCARE
Mar-16
ELDER PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs380454 83.6%   
Low Rs188305 61.7%   
Sales per share (Unadj.) Rs491.296.1 511.2%  
Earnings per share (Unadj.) Rs-3.214.9 -21.4%  
Cash flow per share (Unadj.) Rs14.417.8 80.8%  
Dividends per share (Unadj.) Rs03.20 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.552.3 720.2%  
Shares outstanding (eoy) m20.541,023.74 2.0%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x0.63.9 14.6%   
Avg P/E ratio x-89.325.5 -349.9%  
P/CF ratio (eoy) x19.721.3 92.6%  
Price / Book Value ratio x0.87.3 10.4%  
Dividend payout %021.5 0.0%   
Avg Mkt Cap Rs m5,833388,458 1.5%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m2,17913,317 16.4%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m10,08998,376 10.3%  
Other income Rs m257941 27.3%   
Total revenues Rs m10,34699,317 10.4%   
Gross profit Rs m-79223,829 -3.3%  
Depreciation Rs m3613,022 12.0%   
Interest Rs m2,756486 567.1%   
Profit before tax Rs m-3,65321,262 -17.2%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m3,713-25 -14,850.8%   
Tax Rs m1255,716 2.2%   
Profit after tax Rs m-6515,226 -0.4%  
Gross profit margin %-7.824.2 -32.4%  
Effective tax rate %-3.426.9 -12.7%   
Net profit margin %-0.615.5 -4.2%  
BALANCE SHEET DATA
Current assets Rs m9,24044,376 20.8%   
Current liabilities Rs m9,99834,071 29.3%   
Net working cap to sales %-7.510.5 -71.7%  
Current ratio x0.91.3 71.0%  
Inventory Days Days4654 86.0%  
Debtors Days Days6062 96.1%  
Net fixed assets Rs m10,12447,896 21.1%   
Share capital Rs m2061,024 20.1%   
"Free" reserves Rs m5,58248,746 11.5%   
Net worth Rs m7,73453,519 14.5%   
Long term debt Rs m4,8898,964 54.5%   
Total assets Rs m22,882100,163 22.8%  
Interest coverage x-0.344.7 -0.7%   
Debt to equity ratio x0.60.2 377.4%  
Sales to assets ratio x0.41.0 44.9%   
Return on assets %11.815.7 75.0%  
Return on equity %-0.828.4 -3.0%  
Return on capital %22.334.3 65.1%  
Exports to sales %3.045.3 6.7%   
Imports to sales %0.45.9 7.2%   
Exports (fob) Rs m30744,537 0.7%   
Imports (cif) Rs m435,838 0.7%   
Fx inflow Rs m30744,881 0.7%   
Fx outflow Rs m1259,069 1.4%   
Net fx Rs m18135,812 0.5%   
CASH FLOW
From Operations Rs m11,75419,938 59.0%  
From Investments Rs m-561-9,039 6.2%  
From Financial Activity Rs m-6,762-9,527 71.0%  
Net Cashflow Rs m4,4321,372 323.0%  

Share Holding

Indian Promoters % 39.6 74.8 52.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 8.3 90.4%  
FIIs % 16.8 5.9 284.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 11.0 328.2%  
Shareholders   16,479 44,069 37.4%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   WYETH LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of US Fed Meet, Anti-dumping Duty on Radical Tyres, and Top Stocks in Action Today(Pre-Open)

Indian share markets closed their Wednesday session on a flat note. At the closing bell yesterday, the BSE Sensex closed lower by 2 points and the NSE Nifty finished down by 6 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS